BioBot Analytics

Analyzes wastewater for public health insights

Cambridge, Massachusetts, United States

About BioBot Analytics

Biobot Analytics specializes in wastewater epidemiology, which involves analyzing sewage to gather important public health data. The company serves various clients, including governments, businesses, universities, and health systems, providing insights into community health trends such as the presence of high-risk substances and the spread of diseases. By analyzing wastewater samples, Biobot offers data analysis services that help clients make informed decisions to enhance public health efforts. Unlike its competitors, Biobot focuses specifically on wastewater analysis, providing regular reports and real-time data through a subscription model. The company's goal is to improve health outcomes and equity in community health by transforming wastewater infrastructure into a valuable tool for public health surveillance.

Cambridge, MassachusettsHeadquarters
2017Year Founded
$54.8MTotal Funding
EARLY_VCCompany Stage
Social Impact, HealthcareIndustries
11-50Employees

Benefits

Medical, dental, & vision insurance
Unlimited PTO
Paid parental leave
401k contribution
Home office stipend
Commuter benefits
Free meals

Risks

Competition from Verily in securing government contracts poses a significant challenge.
Over-reliance on government contracts could affect Biobot's financial stability.
Public skepticism about wastewater data usage may hinder widespread adoption.

Differentiation

Biobot transforms wastewater into public health observatories, offering unique epidemiological insights.
The company provides unbiased health data, independent of hospital reporting systems.
Biobot's technology rapidly adapts to emerging public health threats, enhancing community well-being.

Upsides

Biobot secured $30 million funding to enhance its sewage analysis technology.
The nationwide program for high-risk substances monitoring shows strong growth potential.
Lieutenant General H.R. McMaster's board membership may boost national security collaborations.

Funding

Total raised$54.78 M
Latest valuation$150.00 M
StageEARLY_VC